A detailed history of British Columbia Investment Management Corp transactions in Catalent, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 30,192 shares of CTLT stock, worth $1.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,192
Previous 34,659 12.89%
Holding current value
$1.78 Million
Previous $1.95 Million 6.16%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.16 - $60.96 $250,866 - $272,308
-4,467 Reduced 12.89%
30,192 $1.83 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $701,469 - $746,505
13,092 Added 60.7%
34,659 $1.95 Million
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $35,622 - $50,069
837 Added 4.04%
21,567 $1.22 Million
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $144,970 - $209,797
4,505 Added 27.77%
20,730 $931,000
Q2 2023

Aug 11, 2023

BUY
$31.86 - $67.26 $31,891 - $67,327
1,001 Added 6.58%
16,225 $703,000
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $9,406 - $15,371
207 Added 1.38%
15,224 $1 Million
Q4 2022

Feb 10, 2023

SELL
$41.39 - $81.0 $68,790 - $134,622
-1,662 Reduced 9.96%
15,017 $675,000
Q3 2022

Nov 10, 2022

SELL
$72.36 - $113.1 $225,835 - $352,985
-3,121 Reduced 15.76%
16,679 $1.21 Million
Q2 2022

Aug 12, 2022

SELL
$87.2 - $114.05 $577,787 - $755,695
-6,626 Reduced 25.07%
19,800 $2.12 Million
Q1 2022

May 12, 2022

SELL
$94.19 - $124.49 $330,701 - $437,084
-3,511 Reduced 11.73%
26,426 $2.93 Million
Q4 2021

Feb 11, 2022

SELL
$119.57 - $139.07 $183,659 - $213,611
-1,536 Reduced 4.88%
29,937 $3.83 Million
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $8,515 - $11,103
-78 Reduced 0.25%
31,473 $4.19 Million
Q2 2021

Aug 09, 2021

BUY
$100.34 - $115.69 $454,439 - $523,960
4,529 Added 16.76%
31,551 $3.41 Million
Q1 2021

Apr 30, 2021

SELL
$101.51 - $125.27 $71,666 - $88,440
-706 Reduced 2.55%
27,022 $2.85 Million
Q4 2020

Feb 02, 2021

BUY
$85.88 - $105.36 $74,114 - $90,925
863 Added 3.21%
27,728 $2.89 Million
Q3 2020

Nov 10, 2020

BUY
$72.74 - $92.5 $134,278 - $170,755
1,846 Added 7.38%
26,865 $2.3 Million
Q2 2020

Aug 12, 2020

BUY
$48.02 - $79.04 $1.2 Million - $1.98 Million
25,019 New
25,019 $1.83 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.